127 related articles for article (PubMed ID: 2355004)
1. Metabolism-based covalent bonding of the heme prosthetic group to its apoprotein during the reductive debromination of BrCCl3 by myoglobin.
Osawa Y; Martin BM; Griffin PR; Yates JR; Shabanowitz J; Hunt DF; Murphy AC; Chen L; Cotter RJ; Pohl LR
J Biol Chem; 1990 Jun; 265(18):10340-6. PubMed ID: 2355004
[TBL] [Abstract][Full Text] [Related]
2. Characterization by NMR of the heme-myoglobin adduct formed during the reductive metabolism of BrCCl3. Covalent bonding of the proximal histidine to the ring I vinyl group.
Osawa Y; Highet RJ; Bax A; Pohl LR
J Biol Chem; 1991 Feb; 266(5):3208-14. PubMed ID: 1993694
[TBL] [Abstract][Full Text] [Related]
3. Structure of the novel heme adduct formed during the reaction of human hemoglobin with BrCCl3 in red cell lysates.
Osawa Y; Fellows CS; Meyer CA; Woods A; Castoro JA; Cotter RJ; Wilkins CL; Highet RJ
J Biol Chem; 1994 Jun; 269(22):15481-7. PubMed ID: 8195191
[TBL] [Abstract][Full Text] [Related]
4. Covalent alteration of the prosthetic heme of human hemoglobin by BrCCl3. Cross-linking of heme to cysteine residue 93.
Kindt JT; Woods A; Martin BM; Cotter RJ; Osawa Y
J Biol Chem; 1992 May; 267(13):8739-43. PubMed ID: 1577716
[TBL] [Abstract][Full Text] [Related]
5. Metabolism-based transformation of myoglobin to an oxidase by BrCCl3 and molecular modeling of the oxidase form.
Osawa Y; Darbyshire JF; Steinbach PJ; Brooks BR
J Biol Chem; 1993 Feb; 268(4):2953-9. PubMed ID: 8428969
[TBL] [Abstract][Full Text] [Related]
6. Reactions of the protein radical in peroxide-treated myoglobin. Formation of a heme-protein cross-link.
Catalano CE; Choe YS; Ortiz de Montellano PR
J Biol Chem; 1989 Jun; 264(18):10534-41. PubMed ID: 2732236
[TBL] [Abstract][Full Text] [Related]
7. Covalent bonding of the prosthetic heme to protein: a potential mechanism for the suicide inactivation or activation of hemoproteins.
Osawa Y; Pohl LR
Chem Res Toxicol; 1989; 2(3):131-41. PubMed ID: 2519716
[TBL] [Abstract][Full Text] [Related]
8. Heme oxygenase active-site residues identified by heme-protein cross-linking during reduction of CBrCl3.
Wilks A; Medzihradszky KF; Ortiz de Montellano PR
Biochemistry; 1998 Mar; 37(9):2889-96. PubMed ID: 9485440
[TBL] [Abstract][Full Text] [Related]
9. Covalent crosslinking of the heme prosthetic group to myoglobin by H2O2: toxicological implications.
Osawa Y; Williams MS
Free Radic Biol Med; 1996; 21(1):35-41. PubMed ID: 8791091
[TBL] [Abstract][Full Text] [Related]
10. Structure and function of the myoglobin containing octaethylhemin as a prosthetic group.
Neya S; Funasaki N; Imai K
J Biol Chem; 1988 Jun; 263(18):8810-5. PubMed ID: 3379047
[TBL] [Abstract][Full Text] [Related]
11. Preparation and spectral characterization of the heme d1.apomyoglobin complex: an unusual protein environment for the substrate-binding heme of Pseudomonas cytochrome oxidase.
Steup MB; Muhoberac BB
J Inorg Biochem; 1989 Nov; 37(3):233-57. PubMed ID: 2557389
[TBL] [Abstract][Full Text] [Related]
12. Mechanism-based inactivation of cytochrome P450 3A4 by 17 alpha-ethynylestradiol: evidence for heme destruction and covalent binding to protein.
Lin HL; Kent UM; Hollenberg PF
J Pharmacol Exp Ther; 2002 Apr; 301(1):160-7. PubMed ID: 11907170
[TBL] [Abstract][Full Text] [Related]
13. The inactivation of cytochrome P450 3A5 by 17alpha-ethynylestradiol is cytochrome b5-dependent: metabolic activation of the ethynyl moiety leads to the formation of glutathione conjugates, a heme adduct, and covalent binding to the apoprotein.
Lin HL; Hollenberg PF
J Pharmacol Exp Ther; 2007 Apr; 321(1):276-87. PubMed ID: 17251390
[TBL] [Abstract][Full Text] [Related]
14. Cloning, overexpression and characterization of micro-myoglobin, a minimal heme-binding fragment.
Grandori R; Schwarzinger S; Müller N
Eur J Biochem; 2000 Feb; 267(4):1168-72. PubMed ID: 10672027
[TBL] [Abstract][Full Text] [Related]
15. Reconstitution of myoglobin from apoprotein and heme, monitored by stopped-flow absorption, fluorescence and circular dichroism.
Kawamura-Konishi Y; Kihara H; Suzuki H
Eur J Biochem; 1988 Jan; 170(3):589-95. PubMed ID: 3338455
[TBL] [Abstract][Full Text] [Related]
16. Effects of cyanogen bromide modification of the distal histidine on the spectroscopic and ligand binding properties of myoglobin: magnetic circular dichroism spectroscopy as a probe of distal water ligation in ferric high-spin histidine-bound heme proteins.
Bracete AM; Sono M; Dawson JH
Biochim Biophys Acta; 1991 Nov; 1080(3):264-70. PubMed ID: 1954234
[TBL] [Abstract][Full Text] [Related]
17. Serine92 (F7) contributes to the control of heme reactivity and stability in myoglobin.
Smerdon SJ; Krzywda S; Wilkinson AJ; Brantley RE; Carver TE; Hargrove MS; Olson JS
Biochemistry; 1993 May; 32(19):5132-8. PubMed ID: 8494890
[TBL] [Abstract][Full Text] [Related]
18. Modification of the heme distal side in myoglobin by cyanogen bromide. Heme environmental structures and ligand binding properties of the modified myoglobin.
Shiro Y; Morishima I
Biochemistry; 1984 Oct; 23(21):4879-84. PubMed ID: 6498165
[TBL] [Abstract][Full Text] [Related]
19. The association rate constant for heme binding to globin is independent of protein structure.
Hargrove MS; Barrick D; Olson JS
Biochemistry; 1996 Sep; 35(35):11293-9. PubMed ID: 8784183
[TBL] [Abstract][Full Text] [Related]
20. Alteration of the heme prosthetic group of neuronal nitric-oxide synthase during inactivation by N(G)-amino-L-arginine in vitro and in vivo.
Vuletich JL; Lowe ER; Jianmongkol S; Kamada Y; Kent UM; Bender AT; Demady DR; Hollenberg PF; Osawa Y
Mol Pharmacol; 2002 Jul; 62(1):110-8. PubMed ID: 12065761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
